EOLSbenzinga

Evolus Announces FDA Approval Of Evolysse Form And Evolysse Smooth Injectable Hyaluronic Acid Gels; First Major Technological Breakthrough In Hyaluronic Acid Dermal Fillers In A Decade; U.S. Launch Planned In Q2 2025

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on February 13, 2025 by benzinga